Frederic H. Moll, Director at Intersect ENT, Inc. (XENT), sold 14,200 shares at $28.77 ($408K) on 2017-11-16, disclosed to the SEC on 2017-11-20.
Open-market sale of $408k XENT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.77 | 6,700 | $193K | 47.2% |
| 2 | $28.74 | 5,000 | $144K | 35.2% |
| 3 | $28.76 | 2,500 | $72K | 17.6% |
| Total | $28.76 avg | 14,200 | $408K | 100% |
| Filing → |
| SSII | BUY | 2025-02-24 | $10.0M | — | Filing → |
| SSII | BUY | 2025-01-10 | $4.0M | — | Filing → |
| SSII | BUY | 2025-01-03 | $6.0M | — | Filing → |